Modeling the impact of vaccine dose prioritization strategies during the 2022 mpox outbreak
American Journal of Epidemiology · 2025
DOI: 10.1093/aje/kwaf054 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Epidemiology, 2025. Verfasst von Patrick A Clay und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of STD Prevention, National Center for HIV, Hepatitis, STD, and Tuberculosis Prevention, CDC, Atlanta, GA, United States. Hauptthemen laut MEDLINE: Disease Outbreaks, Mpox, Monkeypox, Vaccination. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Intramural CDC HHS.
Abstract (Originalsprache)
Early in the 2022 mpox outbreak, the US recommendation was to administer two doses of the JYNNEOS vaccine 4 weeks apart. However, because of limited vaccine supply, New York City (NYC) prioritized single dose vaccination. We estimated mpox cases averted by this strategy compared to strategies that prioritized 2-dose vaccination for a smaller portion of the population. We fit a network transmission model to incident mpox cases in NYC. Model output consisted of predicted cases over time when vaccine doses were administered with the “first-dose priority” strategy, compared with counterfactual simulations, where doses were administered to those eligible for a second dose ahead of those waiting for a first dose (“intermediate” strategy), or where individuals were preallocated full courses of the vaccine (“second-dose priority” strategy). We estimate that NYC’s strategy averted 66% (IQR, 47%-78%) of potential mpox cases compared to no vaccination. This “first-dose priority” strategy averted 0.6% (IQR, −11% to 9.8%) more cases than the “intermediate” strategy, and 17% (IQR, 2.9%-38%) more cases than the “second-dose priority” strategy. Thus, for the 2022 mpox outbreak in NYC, preallocating vaccine doses to ensure full vaccination in a high-priority subset of the population would have increased the size of the outbreak.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of STD Prevention, National Center for HIV, Hepatitis, STD, and Tuberculosis Prevention, CDC, Atlanta, GA, United States.
- Disease Control, New York City Department of Health and Mental Hygiene, Bureau of Hepatitis, HIV, and STI, Queens, NY, United States.
- Bureau of Immunization, New York City Department of Health and Mental Hygiene, New York, NY, United States.
- National Center for Influenza and Respiratory Diseases, Immunization Services Division, CDC, Atlanta, GA, United States.
- National Center for Emerging and Zoonotic Infectious Diseases, Division of High Consequence Pathogens and Pathology, CDC, Atlanta, GA, United States.
ORCID-Profile: Patrick A Clay, Emily D Pollock, Enrique M Saldarriaga, Preeti Pathela, Michelle Macaraig, Jane R Zucker, Bindy Crouch, Ian Kracalik, Ian H Spicknall
Förderung
- Intramural CDC HHS
Zitieren
APA
Clay, P. A., Pollock, E. D., Saldarriaga, E. M., Pathela, P., Macaraig, M., Zucker, J. R., Crouch, B., Kracalik, I., & Spicknall, I. H. (2025). Modeling the impact of vaccine dose prioritization strategies during the 2022 mpox outbreak. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwaf054
Vancouver
Clay PA, Pollock ED, Saldarriaga EM, Pathela P, Macaraig M, Zucker JR, et al. Modeling the impact of vaccine dose prioritization strategies during the 2022 mpox outbreak. American Journal of Epidemiology. 2025. doi:10.1093/aje/kwaf054
BibTeX
@article{Clay2025,
author = {Clay, Patrick A and Pollock, Emily D and Saldarriaga, Enrique M and Pathela, Preeti and Macaraig, Michelle and Zucker, Jane R and Crouch, Bindy and Kracalik, Ian and Spicknall, Ian H},
title = {Modeling the impact of vaccine dose prioritization strategies during the 2022 mpox outbreak},
journal = {American Journal of Epidemiology},
year = {2025},
doi = {10.1093/aje/kwaf054}
}
EUVIMED